How many Italian cancer patients are eligible for, and may respond to, Italian Medicines Agency-approved checkpoint immune inhibitors?

CONCLUSIONS: In conclusion, although the number of ICI-eligible patients is a relatively small proportion of the yearly burden of cancers, about half of them may respond to ICI-treatment.PMID:38372036 | DOI:10.1177/03008916241229649

Source: Tumori - February 19, 2024 Category: Cancer & Oncology Authors: Emanuele Crocetti Alessandra Ravaioli Fabio Falcini Rosa Vattiato Silvia Mancini Flavia Baldacchini Federica Zamagni Benedetta Vitali Chiara Balducci Lauro Bucchi Orietta Giuliani Source Type: research